English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONS
  This item is discarded!Release HistoryDetailsSummary

Discarded

Meeting Abstract

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

MPS-Authors
/persons/resource/persons38948

Krumbholz,  M.
Department: Neuroimmunology / Wekerle, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38951

Kümpfel,  T.
Department: Neuroimmunology / Wekerle, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38897

Hohlfeld,  R.
Department: Neuroimmunology / Wekerle, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38991

Meinl,  E.
Department: Neuroimmunology / Wekerle, MPI of Neurobiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Krumbholz, M., Meinl, I., Kümpfel, T., Hohlfeld, R., & Meinl, E. (2008). Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Journal of Neuroimmunology, 203(2), 268-269.


Abstract
There is no abstract available